Gollob Jared
Insider CIK 1821198 · KYMR Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-04 | 447 | $86.62 | $38.7K | 117,134 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-04 | 2,519 | $85.04 | $214.2K | 119,018 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-04 | 492 | $84.00 | $41.3K | 121,537 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-04 | 1,437 | $85.78 | $123.3K | 117,581 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2026-03-02 | 2026-03-04 | 35,300 | — | $0 | 35,300 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2026-03-02 | 2026-03-04 | 17,650 | — | $0 | 127,642 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 1,510 | $87.75 | $132.5K | 126,132 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 1,055 | $88.50 | $93.4K | 125,077 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 3,048 | $89.66 | $273.3K | 122,029 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-12-08 | 2025-12-08 | 49,307 | — | $0 | 34,083 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-12-08 | 2025-12-08 | 49,307 | $5.33 | $262.8K | 159,299 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-08 | 1,400 | $92.19 | $129.1K | 109,992 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-08 | 13,759 | $87.37 | $1.20M | 145,540 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-08 | 18,357 | $88.02 | $1.62M | 127,183 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-08 | 3,929 | $89.43 | $351.4K | 123,254 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-08 | 8,562 | $90.12 | $771.6K | 114,692 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-08 | 3,300 | $91.46 | $301.8K | 111,392 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-10-15 | 2025-10-15 | 28,999 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-10-15 | 2025-10-15 | 22,210 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 8,963 | $61.49 | $551.1K | 131,341 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-10-15 | 2025-10-15 | 28,999 | $1.31 | $38.0K | 147,358 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 14,896 | $62.72 | $934.3K | 116,445 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 6,453 | $63.09 | $407.1K | 109,992 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 29,264 | $60.37 | $1.77M | 140,304 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-10-15 | 2025-10-15 | 22,210 | $2.08 | $46.2K | 169,568 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-10-13 | 2025-10-14 | 673 | — | $0 | 22,210 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-10-13 | 2025-10-14 | 800 | — | $0 | 28,999 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-10-13 | 2025-10-14 | 800 | $1.31 | $1.0K | 120,800 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-10-13 | 2025-10-14 | 3,114 | $60.00 | $186.8K | 118,359 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-10-13 | 2025-10-14 | 673 | $2.08 | $1.4K | 121,473 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2025-03-03 | 2025-03-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2025-03-03 | 2025-03-03 | 30,000 | — | $0 | 125,740 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-03-03 | 2025-03-03 | 4,695 | $30.33 | $142.4K | 121,045 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-03-03 | 2025-03-03 | 1,045 | $31.00 | $32.4K | 120,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-07-16 | 2024-07-16 | 23,145 | — | $0 | 22,883 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-07-16 | 2024-07-16 | 23,145 | $2.08 | $48.1K | 118,885 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-16 | 2024-07-16 | 9,864 | $46.10 | $454.7K | 95,470 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-16 | 2024-07-16 | 13,281 | $45.59 | $605.5K | 105,604 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-07-15 | 2024-07-16 | 16,455 | — | $0 | 46,028 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-07-15 | 2024-07-16 | 16,455 | $2.08 | $34.2K | 112,195 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-15 | 2024-07-16 | 16,455 | $45.15 | $742.9K | 95,740 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-04 | 216 | $43.26 | $9.3K | 95,740 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-04 | 1,106 | $42.39 | $46.9K | 95,956 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-04 | 2,022 | $41.41 | $83.7K | 97,062 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 146,250 | — | $0 | 146,250 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2024-03-01 | 2024-03-04 | 24,375 | — | $0 | 99,084 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-02-27 | 2024-02-29 | 400 | — | $0 | 62,483 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-29 | 400 | $45.00 | $18.0K | 74,709 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-02-27 | 2024-02-29 | 400 | $2.08 | $832 | 75,109 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-02-09 | 2024-02-09 | 46,137 | — | $0 | 62,883 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-02-09 | 2024-02-09 | 7,398 | $36.09 | $267.0K | 74,709 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-02-09 | 2024-02-09 | 38,739 | $35.39 | $1.37M | 82,107 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-02-09 | 2024-02-09 | 46,137 | $2.08 | $96.0K | 120,846 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2023-03-02 | 2023-03-03 | 297 | $31.40 | $9.3K | 74,709 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2023-03-02 | 2023-03-03 | 1,001 | $30.88 | $30.9K | 75,006 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 112,500 | — | $0 | 112,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2023-03-01 | 2023-03-03 | 18,750 | — | $0 | 76,007 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-05-04 | 2022-05-04 | 9,792 | — | $0 | 109,020 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-05-04 | 2022-05-04 | 10,208 | — | $0 | 29,799 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-05-04 | 2022-05-04 | 9,792 | $2.08 | $20.4K | 57,257 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-05-04 | 2022-05-04 | 10,208 | $1.31 | $13.4K | 47,465 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 75,800 | — | $0 | 75,800 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2022-03-01 | 2022-03-03 | 12,600 | — | $0 | 37,257 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-11-02 | 2021-11-02 | 14,996 | — | $0 | 118,812 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-11-02 | 2021-11-02 | 5,280 | $63.50 | $335.3K | 25,859 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-11-02 | 2021-11-02 | 8,514 | $62.89 | $535.4K | 31,139 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-11-02 | 2021-11-02 | 14,996 | $2.08 | $31.2K | 39,653 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-11-02 | 2021-11-02 | 1,202 | $64.34 | $77.3K | 24,657 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-11-01 | 2021-11-02 | 20,000 | — | $0 | 40,007 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-11-01 | 2021-11-02 | 4,607 | — | $0 | 133,808 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-11-01 | 2021-11-02 | 15,134 | $61.50 | $930.7K | 44,633 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-11-01 | 2021-11-02 | 20,000 | $1.31 | $26.2K | 62,547 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-11-01 | 2021-11-02 | 4,607 | $2.08 | $9.6K | 67,154 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-11-01 | 2021-11-02 | 4,065 | $63.17 | $256.8K | 24,657 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-11-01 | 2021-11-02 | 15,911 | $62.34 | $991.9K | 28,722 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-11-01 | 2021-11-02 | 7,387 | $60.40 | $446.2K | 59,767 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-03-15 | 2021-03-15 | 7,800 | — | $0 | 60,007 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-03-15 | 2021-03-15 | 10,305 | $60.17 | $620.1K | 42,547 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-03-15 | 2021-03-15 | 7,800 | $1.31 | $10.2K | 52,852 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-03-11 | 2021-03-15 | 2,200 | — | $0 | 67,807 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-03-11 | 2021-03-15 | 4,695 | $60.05 | $281.9K | 45,052 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-03-11 | 2021-03-15 | 2,200 | $1.31 | $2.9K | 49,747 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-02-24 | 2021-02-24 | 8,675 | $50.91 | $441.6K | 47,547 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-02-23 | 2021-02-24 | 19,285 | $49.65 | $957.5K | 56,222 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-02-22 | 2021-02-24 | 9,104 | $52.63 | $479.1K | 75,507 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-02-19 | 2021-02-19 | 8,887 | $55.09 | $489.6K | 84,611 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-02-18 | 2021-02-19 | 6,499 | $55.94 | $363.6K | 93,498 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-02-17 | 2021-02-19 | 7,550 | $58.39 | $440.8K | 99,997 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2020-08-20 | 2020-08-21 | 48,942 | — | $0 | 48,942 | SEC↗ |